Bridgebio Oncology TherapeutBBOT
13F holders, Q1 2025 (March 31)At the end of Q1 2025, 31 institutions reported holding Bridgebio Oncology Therapeut (BBOT) in their 13F filings, down 1 from Q4 2024. 3 opened new positions and 4 sold out. The largest holders were Cormorant Asset Management, LP ($32.9M), BlackRock, Inc. ($16.9M) and Citadel Advisors ($16.0M). 3 famous investors held it, including George Soros (0.0% of Soros Fund Management's portfolio), Ken Griffin (0.0% of Citadel Advisors's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Bridgebio Oncology Therapeut
- Filed as
- HELIX ACQUISITION CORP II (Q1 2025)
- CUSIP
- G4444H101
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $7.1M |
| Exits | 4 | $8.1M |
All 13F filers, Q4 2024 → Q1 2025: 1,434,586 shares bought and 1,392,374 shares sold, net +42,212 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 31 holders
| Cormorant Asset Management, LP | 2.49% | No change | 2,909,000 | $32.9M |
| BlackRock, Inc. | 0.00% | No change | 1,498,865 | $16.9M |
| Citadel Advisors | 0.02% | Add +5.4% | 1,411,960 | $16.0M |
| Adage Capital Partners Gp, L.L.C. | 0.03% | No change | 1,400,000 | $15.8M |
| Millennium Management | 0.01% | Reduce -4.0% | 1,096,382 | $12.4M |
| T. Rowe Price Associates Inc. | 0.00% | Reduce -1.5% | 1,071,550 | $12.1M |
| Sculptor Capital LP | 0.32% | Add +13.5% | 800,000 | $9.0M |
| Silverarc Capital Management, LLC | 1.45% | Add +19.5% | 613,393 | $6.9M |
| Farallon Capital Management, L.L.C. | 0.04% | No change | 600,000 | $6.8M |
| Harraden Circle Investments, LLC | 2.91% | Add +104.7% | 526,535 | $5.9M |
| ADAR1 Capital Management, LLC | 1.05% | Add +16.2% | 469,729 | $5.3M |
| Perceptive Advisors LLC | 0.16% | Reduce -20.4% | 398,000 | $4.5M |
| T. Rowe Price Investment Management, Inc. | 0.00% | Reduce -0.6% | 397,962 | $4.5M |
| Fort Baker Capital Management LP | 1.32% | New | 374,683 | $4.2M |
| Great Point Partners LLC | 2.30% | Reduce -25.2% | 373,833 | $4.2M |
| Laurion Capital Management LP | 0.27% | No change | 300,000 | $3.4M |
| Octagon Capital Advisors LP | 0.61% | No change | 250,000 | $2.8M |
| Decagon Asset Management LLP | 2.49% | Add +28.4% | 239,403 | $2.7M |
| Stempoint Capital LP | 0.73% | No change | 200,900 | $2.3M |
| Two Sigma Investments, LP | 0.00% | No change | 189,285 | $2.1M |
| Acuta Capital Partners, LLC | 2.45% | Add +3.5% | 187,257 | $2.1M |
| Wellington Management Group LLP | 0.00% | No change | 184,590 | $2.1M |
| JPMorgan Chase & Co. | 0.00% | New | 152,216 | $1.7M |
| Soros Fund Management | 0.04% | Reduce -68.4% | 150,000 | $1.7M |
| TD Asset Management Inc | 0.00% | No change | 144,772 | $1.6M |
| Toronto Dominion Bank | 0.00% | Add +178.8% | 138,000 | $1.6M |
| Woodline Partners LP | 0.01% | No change | 103,247 | $1.2M |
| K2 Principal Fund, L.P. | 0.64% | New | 100,000 | $1.1M |
| Moore Capital Management, LP | 0.04% | No change | 100,000 | $1.1M |
| UBS Group AG | 0.00% | Add +165.1% | 92,660 | $1.0M |
| Geode Capital Management, LLC | 0.00% | No change | 13,274 | $150K |
"% of holder's portfolio" is BBOT's weight in each manager's 13F, not the share of Bridgebio Oncology Therapeut the manager owns.